Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
I see Emma Walmsley – the current (but surely not for much longer) CEO of GlaxoSmithKline (GSK) – is very excited this morning, after the company announced hiring a new Chief Scientific Officer designate who will take the full job in August. I do agree with Emma that the appointment is positive and important, but I do wonder whether there will be also be a newly announced Glaxo CEO come August, irrespective of the company’s big intellectual and R&D push over the next few years. Even if Glaxo shares are back below 17 quid, you know my continuing positive thoughts as mentioned a few days ago HERE. Meanwhile, let’s talk about Burberry (BRBY).
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.